Viewing Study NCT01961102



Ignite Creation Date: 2024-05-06 @ 2:04 AM
Last Modification Date: 2024-10-26 @ 11:13 AM
Study NCT ID: NCT01961102
Status: COMPLETED
Last Update Posted: 2016-08-09
First Post: 2013-10-09

Brief Title: OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer
Sponsor: Krankenhaus Barmherzige Schwestern Linz
Organization: Krankenhaus Barmherzige Schwestern Linz

Study Overview

Official Title: Pilot-study of OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer
Status: COMPLETED
Status Verified Date: 2015-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: It is to be achieved that in postmenopausal women through the combination of Hysteroscopy and intraoperative rapid section a positive predictive value PPV regarding the objective illness like endometrial cancer or adenomatous hyperplasia of 100 so as a negative predictive value NPV of 99
Detailed Description: If a patient fulfills the inclusion criteria the surgeon decides intraoperatively due to the aspect in the hysteroscopy if it is a clearly benign result or if it looks suspicious or malign

In case of a hysteroscopical benign result the patient will be informed about the result after the operation

In case of a hysteroscopal suspicious or malignant aspect the curettement will be sent for a rapid section If the hysteroscopic result confirms the hysteroscopic suspicion the patient will be informed after the operation and the further treatment can be planned right away

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None